Acciones F-star Therapeutics, Inc.
Acciones
FSTX
US30315R1077
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20/11/20 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 20/11/20 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,28 % | 103 mil M | |
+0,55 % | 95,71 mil M | |
+1,69 % | 22,02 mil M | |
-17,12 % | 20,9 mil M | |
-9,30 % | 17,85 mil M | |
-41,01 % | 16,21 mil M | |
-14,83 % | 15,52 mil M | |
+3,13 % | 13,86 mil M | |
+34,20 % | 12,04 mil M |